FDA Drug Application (083919) for MILTOWN by MEDPOINTE PHARM HLC

Back to FDA Applications sponsored by MEDPOINTE PHARM HLC

Application Number083919
Product Number001
FormTABLET;ORAL
Dosage600MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMILTOWN
Active IngredientMEPROBAMATE

Active IngredientCount
List of drugs with Active Ingredient MEPROBAMATE18


Back to FDA Applications sponsored by MEDPOINTE PHARM HLC